Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 874 of 5804
-
New combo therapy aims to control returning lung cancer in targeted patients
Disease control Recruiting nowThis study is designed as a multi-cohort trial based on various patient biomarkers study with the potential to include new study treatment in the future. EGFR-sensitive mutation-positive patients with distant recurrence after adjuvant osimertinib treatment for EGFRm resectable SI…
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Pilot study tests safer blood thinner options for pregnant women with mechanical heart valves
Disease control Recruiting nowThe purpose of this pilot study is to collect data on pregnancies with mechanical heart valves to see if using a blood thinner called low molecular weight heparin (LMWH) and low dose aspirin (LDA) is comparable to warfarin/vitamin K antagonist (VKA) to reduce the chance of clotti…
Phase: NA • Sponsor: Mount Sinai Hospital, Canada • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
AI reads skin lesions to predict cancer aggressiveness
Knowledge-focused Recruiting nowThis retrospective observational study aims to develop and evaluate a convolutional neural network (CNN)-based artificial intelligence model for risk classification and histopathological subtype prediction of basal cell carcinoma (BCC) using clinical and dermoscopic images. Histo…
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to heal hearts after major attack
Disease control Not yet recruitingThe goal of this phase IIc clinical trial is to learn if recombinant human thymosin beta 4 injection (NL005) works to treat heart damage in people who have had a serious type of heart attack called ST-segment elevation myocardial infarction (STEMI) and have been treated with emer…
Phase: PHASE2 • Sponsor: Beijing Northland Biotech. Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Liver transplant kids test cutting meds in half
Disease control Recruiting nowThis is a prospective multi-center, longitudinal study to determine efficacy of 50 percent Immunosuppression (IS) reduction. One hundred fully eligible participants will reduce IS by 50 percent in two steps. Liver tests will be checked every 0.5 months through month 4, once a mon…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can an injection restore hearing? new trial tests DX243 in older adults
Disease control Recruiting nowPhase 2a: Multiple Ascending Dose (MAD) in male and female patients with hearing loss: The study will be conducted according to a randomised, placebo-controlled, double-blind design. A total of 24 patients, otherwise healthy, aged up to 75 years old, with mild to moderate hearin…
Phase: PHASE2 • Sponsor: Dendrogenix • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Real-world data on semaglutide weight loss in 35,000 adults
Disease control Recruiting nowThe purpose of the study is to assess the weight loss in participants treated with commercially available semaglutide according to routine clinical practice at the discretion of the treating physician.
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New radiation technique aims to zap prostate tumors with fewer side effects
Disease control Recruiting nowThis clinical trial tests the effect of focal radiation therapy, high dose rate-brachytherapy (HDR-BT), in treating patients with prostate cancer. Prostate cancer is the most diagnosed cancer in men and there are many treatments available, including surgery and radiation therapy.…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New weight loss drugs enter human testing – could they beat placebo?
Disease control Recruiting nowThis study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Gene therapy gel targets rare blistering skin disease
Disease control Recruiting nowAn open-label study to evaluate the safety and efficacy of KB111 in pediatric and adult subjects with Hailey-Hailey Disease
Phase: EARLY_PHASE1 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New support team aims to bridge the gap from hospital to mental health care for psychosis
Disease control Recruiting nowThis study is testing a new approach to help people with first episode psychosis transition successfully from the hospital to outpatient mental health care. Many patients lose contact with services after they leave the hospital, which can lead to worse outcomes. The investigators…
Sponsor: University of Chicago • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Fibroid removal before IVF: a Game-Changer for fertility?
Disease control Not yet recruitingUterine fibroids are the most common benign tumors of the female reproductive system and are frequently encountered in women of reproductive age. Although many fibroids are asymptomatic, 5%-10% of women with infertility have coexisting fibroids, and in a small proportion fibroids…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
AI could slash unnecessary prostate biopsies in 'Gray Zone' patients
Diagnosis OngoingThis project aims to develop a precision screening and diagnostic solution for prostate cancer based on multimodal artificial intelligence, focusing on addressing the diagnostic challenge in patients within the PSA "gray zone" of 4-10 ng/mL. The project will integrate multidimens…
Sponsor: Guangxi Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a brain lipid injection ease Parkinson's motor swings?
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 2 study. A total of 276 eligible Parkinson's disease participants with motor fluctuations will be enrolled and assigned to one of three cohorts. Within each cohort, participants will be ran…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could an Alzheimer's drug slow Parkinson's? new trial aims to find out
Disease control Not yet recruitingThis study aimed to determine the efficacy of amyloid clearance of lecanemab in patients with Parkinson's disease (PD) with amyloid co-pathology. Lecanemab, an anti-amyloid monoclonal antibody, was apporoved by the US FDA in July 2023 and in South Korea in May 2024, as a disease-…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to improve breast cancer treatment before surgery
Knowledge-focused Not yet recruitingThis study is an observational study that retrospectively collects data of triple-negative breast cancer patients who received neoadjuvant therapy. It compares the bpCR rate, apCR rate, and tpCR rate of patients treated with chemotherapy or immunotherapy, in order to analyze the …
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood test may spot hidden breast cancer months before scans
Diagnosis Not yet recruitingTriple-negative breast cancer (TNBC) is an aggressive type of breast cancer, often with poor outcomes. Currently, follow-up for TNBC consists of physical exams and annual breast imaging, with additional scans only if symptoms appear. This approach may delay the detection of the c…
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Can a THC-Based drug calm Alzheimer's agitation? new trial aims to find out
Symptom relief Not yet recruitingThis study tests a medication called dronabinol in people with Alzheimer's disease. First, participants go through up to 4 weeks of screening. Then, over 2 weeks, the dose of the study drug is slowly increased. For the next 10 weeks, participants stay on either dronabinol or a pl…
Phase: PHASE2, PHASE3 • Sponsor: Benuvia Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could a biologic drug free severe asthma patients from High-Dose steroids?
Disease control ENROLLING_BY_INVITATIONTo evaluate the relationship between starting tezepelumab treatment followed by tapering of inhaled corticosteroid (ICS) and ICS dose, metabolic outcomes, asthma control and exacerbation rate in a real world setting
Sponsor: Franciscus Gasthuis • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
AI-Powered ECG may spot hidden heart disease in just one minute
Diagnosis Not yet recruitingIt is a prospective, controlled, single-center, non-randomized, observational study. Two patient groups are planned for inclusion: the first - 200 patients with significant coronary artery stenosis confirmed by coronary angiography (CAG) or multislice computed tomography (MSCT) r…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC